Netherton Syndrome
Age: 18 years and older
Location: Rancho Santa Margarita, CA
More information: Clinicaltrials.gov
Clinical Trial for Netherton Syndrome
We are conducting clinical studies on new treatments for Netherton syndrome. If you or anyone you know has been diagnosed with Netherton syndrome and is interested in participating in a clinical trial, please complete our short form at the bottom of the page to determine your eligibility. A member of our team of medical professionals will then contact you to ask a few questions. Please be aware that the consultation is free, and there are no obligations.
Study Details
Sponsor: Boehringer Ingelheim
Summary : This study is open to people with a skin disease called Netherton syndrome (NS). People can join the study if they are 12 years and older. The purpose of this study is to find out whether a medicine called spesolimab helps people with NS. Participants are divided into a spesolimab and a placebo group. Placebo injections look like spesolimab injections but do not contain any medicine. Every participant has a 2 in 3 chance of being in the spesolimab group. In the beginning, participants get the study medicine as an injection into a vein. Afterwards, they get it as an injection under the skin every month. After 4 months, participants in the placebo group switch to spesolimab treatment. Participants are in the study for about 1 year. During this time, they visit the study site 16 times. Where possible, 4 of 16 visits can be done at the participant's home instead of the study site. The doctors regularly check participants' NS symptoms. The results are compared between the groups to see whether spesolimab works. The doctors also regularly check participants' general health and take note of any unwanted effects. (summary from Clinicaltrials.gov)
Trial Name: EvasayilTM : A placebo-controlled trial to evaluate the efficacy and safety of Spesolimab in the treatment of patients with Netherton syndrome
Keywords: Netherton syndrome, Spesolimab, infusion, injection
